In this issue:
– Non-invasive disease severity index for IBD
– Liraglutide for ileal pouch-anal anastomosis and chronic high bowel frequency
– Thiopurine therapeutic drug monitoring
– Pregnancy and stomas
– Optimising triage of urgent referrals for suspected IBD
– Serum infliximab concentrations associated with deep remission
– Subcutaneous infliximab biosimilar as maintenance therapy for IBD
– Long-term outcomes after early ileal resection for CD
– Need for therapeutic escalation in refractory ulcerative proctitis
– Science blog: tumour necrosis factor-like ligand 1A inhibition in IBD
Expert contributor
Michael studied in Erlangen-Nuremberg and trained in Manchester, London and Regensburg, Germany. He went to Chapel Hill, NC at the University of North Carolina for his postdoctoral fellowship. Michael joined the Department of Medicine at the University of Otago in 2005, taking up a joint clinical position as a Senior Lecturer and Gastroenterologist with Te […]
Expert contributor
BSc,MBBS,MD,FRCP,FRACP, Consultant Gastroenterologist (Retd) Dr Srikantaiah Manjunatha (Manju) is a former Consultant Gastroenterologist for Te Whatu Ora–Southern, Dunedin and Honorary Senior Clinical Lecturer at the University of Otago. After completing his MBBS from the University of Mysore in India and MD (Medicine) from the prestigious PGIMER (Post graduate institute of Medical Education & Research), Chandigarh, […]
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.